Key clinical point: Gender-karyotype mismatches can identify transgender patients but some of these patients may be overlooked.
Major finding: Of the all the patients analyzed, 0.3% had a gender-karyotype mismatch.
Study details: Data from 1,748 patients with acute myeloid leukemia or myelodysplastic syndromes enrolled in five Southwest Oncology Group (SWOG) trials.
Disclosures: Dr. Alpert and her colleagues did not disclose any conflicts of interest. The Acute Leukemia Forum is organized by Hemedicus, which is owned by the same company as this news organization.
REPORTING FROM ALF 2019